Showing results (61-70 of 940) with videos related to
Sort By:
Pageof 94
Neurology and Therapy|June 27, 2024
Lymphopenia is Not the Primary Therapeutic Mechanism of Diroximel Fumarate in Relapsing-Remitting Multiple Sclerosis: Subgroup Analyses of the EVOLVE-MS-1 StudyBarry A Singer, Sibyl Wray, Mark Gudesblatt, et al.Neurology and Therapy|January 18, 2023
Comparative Effectiveness of Carbidopa/Levodopa Enteral Suspension and Deep Brain Stimulation on Pill Burden Reduction in Medicare Fee-for-Service Patients with Advanced Parkinson's DiseaseMichael J Soileau, Fernando L Pagan, Alfonso Fasano, et al.Neurology and Therapy|December 23, 2022
The Place of Immune Reconstitution Therapy in the Management of Relapsing Multiple Sclerosis in France: An Expert ConsensusJerome De Sèze, Laurent Suchet, Claude Mekies, et al.Neurology and Therapy|November 24, 2022
Treatment Preference for Alzheimer's Disease: A Multicriteria Decision Analysis with Caregivers, Neurologists, and PayorsGeorge Dranitsaris, Quanwu Zhang, Alex Quill, et al.Neurology and Therapy|January 21, 2019
Intravenous Milrinone Salvage Therapy in Acute Internal Carotid Artery Occlusion: Case ReportHosam Al-Jehani, Mark AngleNeurology and Therapy|December 28, 2020
Potential Neuroregenerative and Neuroprotective Effects of Uridine/Choline-Enriched Multinutrient Dietary Intervention for Mild Cognitive Impairment: A Narrative ReviewBarry S Baumel, P Murali Doraiswamy, Marwan Sabbagh, et al.Neurology and Therapy|December 14, 2019
An Update on Blood-Based Markers of Alzheimer's Disease Using the SiMoA PlatformDanni Li, Michelle M MielkeNeurology and Therapy|December 14, 2019
Critical Steps to be Taken into Consideration Before Quantification of β-Amyloid and Tau Isoforms in Blood can be Implemented in a Clinical EnvironmentHugo Marcel Vanderstichele, Charlotte E Teunissen, Eugeen VanmechelenNeurology and Therapy|June 24, 2021
Confirmed 6-Month Disability Improvement and Worsening Correlate with Long-term Disability Outcomes in Alemtuzumab-Treated Patients with Multiple Sclerosis: Post Hoc Analysis of the CARE-MS StudiesSamuel F Hunter, Rany A Aburashed, Raed Alroughani, et al.Neurology and Therapy|June 3, 2022
Therapeutic Decision-Making Under Uncertainty in the Management of Spinal Muscular Atrophy: Results From DECISIONS-SMA StudyGustavo Saposnik, Ana Camacho, Paola Díaz-Abós, et al.Pageof 94